Shanghai Pharmaceuticals Holding Co (SHSE:601607) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:601607 Shanghai Pharmaceuticals Holding Co Ltd SHSE:601607
74 GF Score
Price ¥16.04
GF Value ¥19.84
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Pharmaceuticals Holding Co Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

SHSE:601607
74GF Score
Shanghai Pharmaceuticals Holding Co Ltd SHSE:601607
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai Pharmaceuticals Holding Co (SHSE:601607) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued. The current stock price of ¥16.04 is trading 19.2% below its estimated GF Value™ of ¥19.84. GuruFocus considers Shanghai Pharmaceuticals Holding Co to be Modestly Undervalued.

Key valuation signals for SHSE:601607:

  • Dividends Received:
  • GF Value™: ¥19.84 vs. price of ¥16.04 (19.2% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the SHSE:601607 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Pharmaceuticals Holding Co Business Description

Other Exchanges 02607:Hong KongS1R:Germany
Address No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding Co Ltd is a China-based integrated healthcare group engaged in pharmaceutical manufacturing, distribution, and retail. Its largest segment by revenue is pharmaceutical distribution, which provides warehousing, logistics, and value-added supply chain services to hospitals, pharmacies, and other dispensers across China. The manufacturing segment develops, produces, and sells a broad portfolio of generic and branded drugs, traditional Chinese medicines, and healthcare products through subsidiaries including Shanghai Pharma and Changzhou Qianhong. The retail segment operates a network of pharmacy stores, largely under brands such as Huashi and Leiyunshang. The company also holds stakes in pharmaceutical research and has expanded internationally through acquisitions in the United States and Europe. Its customers include hospitals, healthcare institutions, retail pharmacies, and pharmaceutical manufacturers. Revenue is generated primarily through drug distribution, product sales, and retail operations, with the vast majority of business conducted in the People's Republic of China.
74GF Score

Get the complete analysis for SHSE:601607

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥16.04
Price
¥19.84
GF Value